EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Peptide-MHC-targeted engineered virus-like particles enable selective priming and gene editing of tumor-specific T cells

Brian H Shim, Q Henry Zhao, Jack A Queenan, Blake E Smith, Michael E Birnbaum, David R Liu

Cell Reports · 2026-06 · 45 (6) · 117510

DOI: 10.1016/j.celrep.2026.117510 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026-06. Verfasst von Brian H Shim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA; Department of Chemistry and Ch…. Hauptthemen laut MEDLINE: Gene Editing, Peptides, Major Histocompatibility Complex, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NHGRI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingPeptidesMajor Histocompatibility ComplexCD8-Positive T-LymphocytesLymphocytes, Tumor-InfiltratingT-LymphocytesHumansAnimalsCell Line, TumorMice

Stichwörter der Autor:innen

CP: cancerTIL therapygene editinggenomicstargeted deliveryvirus-like particles

Substanzen

Peptides

Autor:innen und Institutionen

  • Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA; Howard Hughes…
  • Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.
  • Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA…

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • NHGRI NIH HHS
  • Center for Advanced Materials Processing, Clarkson University
  • Prime Minister's Office Singapore
  • Bill and Melinda Gates Foundation
  • Singapore-MIT Alliance for Research and Technology Centre
  • MIT Koch Institute

Zitieren

APA

Shim, B. H., Zhao, Q. H., Queenan, J. A., Smith, B. E., Birnbaum, M. E., & Liu, D. R. (2026). Peptide-MHC-targeted engineered virus-like particles enable selective priming and gene editing of tumor-specific T cells. Cell Reports, 45(6), 117510. https://doi.org/10.1016/j.celrep.2026.117510

Vancouver

Shim BH, Zhao QH, Queenan JA, Smith BE, Birnbaum ME, Liu DR. Peptide-MHC-targeted engineered virus-like particles enable selective priming and gene editing of tumor-specific T cells. Cell Reports. 2026;45(6):117510. doi:10.1016/j.celrep.2026.117510

BibTeX
@article{Shim2026,
  author = {Shim, Brian H and Zhao, Q Henry and Queenan, Jack A and Smith, Blake E and Birnbaum, Michael E and Liu, David R},
  title = {Peptide-MHC-targeted engineered virus-like particles enable selective priming and gene editing of tumor-specific T cells},
  journal = {Cell Reports},
  year = {2026},
  volume = {45},
  number = {6},
  pages = {117510},
  doi = {10.1016/j.celrep.2026.117510}
}
Kostenlos starten →